China 2010 Pharmaceutical R&D Summit, is the premier China R&D event exploring business-critical issues relating to the pharmaceutical development in China. Attendee will hear from global companies like Pfizer, Sanofi-Aventis and Merck who will share their restructured models and emerging market strategies with us while domestic companies like Jiangsu Hengrui, Simcere and Hutchison will share their insider views on China's pharma industry today. WHO and the Gates Foundation will join us to discuss partnerships between foundations, academia and industry to foster faster development of new therapies for unmet medical needs in developing countries.
Event Highlights
- 4 outstanding Keynotes from Pfizer USA, Sanofi-Aventis France, Merck China and Jiangsu Hengrui Medicine Co., China
- 2 Featured Speakers from WHO and Bill & Melinda Gates Foundation
- China R&D Leaders' Roundtable - Exploring China's Pharma Industry from the Insiders' Eyes
- Spotlight on - Impact of China's Healthcare Reform on MNCs and Domestic Companies
- Investment Panel - The Future of Biotechnology Investing in China
- Focused sessions on:
- Other Emerging Markets vis-a-vis China
- Organizational Development & Talent Management
- Academic Research & Scientific Advances
- Clinical Development Strategies - from FIH to Post-marketing Studies
- Biologics & Biosimilars Development - from Global Outlook to Local R&D
- Plus! Announcing IBC's first China Pharma R&D Awards - presentation & dinner
- Plus! 2 Pre-Conference Workshops to choose from
- I: Implementing Best Practices in Animal Research
- II: What Every Small & Medium-Sized Company Needs to Know about IP Procurement & Enforcement
Plus! 2 Pre-Conference Workshops to Choose From!
- I: Implementing Best Practices in Animal Research
- II: What Every Small and Medium-Sized Company Needs to Know about IP Procurement & Enforcement